Antiangiogenic Therapy and Ovarian Cancer

Authors: Penson, Richard T.; Rauh-Hain, J. A.; Horowitz, Neil S.

Source: Current Women's Health Reviews, Volume 4, Number 1, February 2008 , pp. 33-44(12)

Publisher: Bentham Science Publishers

Buy & download fulltext article:

OR

Price: $62.88 plus tax (Refund Policy)

Abstract:

Epithelial ovarian cancer is the most lethal of gynecologic malignancies in the United States and while current therapies are successful for many years, cure remains elusive. Angiogenesis is the physiological process of new blood vessel growth, and a normal process in growth, development, and wound healing. However, angiogenesis is also a fundamental step in the transition of tumors from a dormant state to a malignant state. Preclinical data and preliminary clinical data suggest that antiangiogenic therapy targeting the vascular endothelial growth factor (VEGF) pathway will change the natural history of epithelial ovarian cancer. With a proven survival advantage in a growing number of tumor types, antiangiogenenic therapy is an exciting field. Important questions remain: the mechanism of activity, optimal integration with chemotherapy, and the benefits and risks of targeting multiple pathways, these are being addressed through a series of clinical trials, designed to evaluate the tumor microenvironment and surrogate endpoints, such as wound healing, leading to a more rationale triaging of patients to this potentially dangerous and costly therapy. The scientific background, and clinical trials with novel agents are reviewed in this exciting new paradigm of care.

Keywords: Vascular Endothelial Growth Factor; Bevacizumab; Sorafenib; Cisplatin; PET scans

Document Type: Research article

DOI: http://dx.doi.org/10.2174/157340408783572079

Publication date: 2008-02-01

More about this publication?
  • Current Women's Health Reviews publishes frontier reviews on all the latest advances on obstetrics and gynecology. The journal's aim is to publish the highest quality review articles dedicated to research in the field. The journal is essential reading for all clinicians and researchers in the fields of obstetrics and gynecology.
Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page